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Background: To safely treat lung tumors using particle radiation therapy (PRT),
motion-mitigation strategies are of critical importance to ensure precise irradiation.
Therefore, we compared applicability, effectiveness, reproducibility, and subjects’
acceptance of enhanced deep-inspiration breath hold (eDIBH) with high-frequency
percussive ventilation (HFPV) by MRI assessment within 1 month.
Methods: Twenty-one healthy subjects (12 males/9 females; age: 49.5 ± 5.8 years;
BMI: 24.7 ± 3.3 kg/m−2) performed two 1.5 T MRI scans in four visits at weekly intervals
under eDIBH and HFPV conditions, accompanied by daily, home-based breath-hold
training and spirometric assessments over a 3-week period. eDIBH consisted of 8-min
100% O2 breathing (3min resting ventilation, 5min controlled hyperventilation) prior
to breath hold. HFPV was set at 200–250 pulses min−1 and 0.8–1.2 bar. Subjects’
acceptance and preference were evaluated by questionnaire. To quantify inter- and
intrafractional changes, a lung distance metric representing lung topography was
computed for 10 reference points: a motion-invariant spinal cord and nine lung structure
contours (LSCs: apex, carina, diaphragm, and six vessels as tumor surrogates distributed
equally across the lung). To parameterize individual LSC localizability, measures of
their spatial variabilities were introduced and lung volumes calculated by automated
MRI analysis.
Results: eDIBH increased breath-hold duration by >100% up to 173 ± 73 s at visit 1,
and to 217± 67 s after 3 weeks of home-based training at visit 4 (p< 0.001). Measures of
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vital capacity and lung volume remained constant over the 3-week period. Two vessels in
the lower lung segment and the diaphragm yielded a two- to threefold improved positional
stability with eDIBH, whereby absolute distance variability was significantly smaller for five
LSCs;≥70% of subjects showed significantly better intrafractional lung motion mitigation
under reproducible conditions with eDIBH compared with HFPV with smaller ranges
most apparent in the anterior-posterior and cranial-caudal directions. Approximately
80% of subjects preferred eDIBH over HFPV, with “less discomfort” named as most
frequent reason.
Conclusions: Both, eDIBH, and HFPV were well-tolerated. eDIBH duration was long
enough to allow for potential PRT. Variability in lung volume was smaller and position of
lung structures more precise with eDIBH. Subjects preferred eDIBH over HFPV. Thus,
eDIBH is a very promising tool for lung tumor therapy with PRT, and further investigation
of its applicability in patients is warranted.
Keywords: breath hold, enhanced DIBH, HFPV, proton therapy, lung cancer, motion mitigation, MRI, lung volume
INTRODUCTION
The safe, accurate, and effective delivery of a highly conformal
dose to the tumor while sparing adjacent healthy tissues
represents the central challenge in the delivery of external beam
radiation therapy (1–4). A fundamental advantage of particle
radiation therapy (PRT) is the steep dose gradient at the distal
edge, which allows protons and carbon ions to deliver their
therapeutic dose with a precisely defined, energy-dependent
finite range distribution (4, 5). This highly sophisticated level
of spatial precision requires exact knowledge of the tumor in
space and time during the entire treatment, especially in the
presence of motion (6, 7). This also includes the time-dependent
distribution of the materials along the particle trajectory, since
the materials’ electron densities have a significant influence on
particle range.
With respect to proton therapy for mobile tumors, e.g.,
lung tumors, using pencil beam scanning (PBS-PT), the
following factors are the major challenges to delivering the
intended dose distribution (7–10): (i) target failures due to
interfractional tumor changes regarding position, shape, and
size; (ii) dose blurring due to interfractional changes in the
patient’s anatomy due to density variations along the beam
path, and (iii) intrafractional interplay between the dynamics
of the beam and the motion of anatomical structures due to
respiration, heartbeat, gastrointestinal peristalsis, and inertial
organ relaxation. The problem of treating lung tumors with
PBS-PT was already discussed in 1992 (11), and the delivery
of such treatments has gradually evolved since (12, 13).
All main components of proton therapy workflows are now
time dependent, including motion analysis and modeling,
multimodal imaging, contouring, treatment planning, dose
delivery techniques, and integrated patient monitoring (14–
17). So-called 4D treatment strategies and motion management
concepts continue to be developed to cope with this temporal
dependence and to meet the corresponding specific challenges of
proton range uncertainties (18–21).
In practice, these approaches can be divided into techniques
which either manipulate the treatment beam (e.g., tracking,
gating, rescanning, robust optimization, etc.,) (22–25) or those
that mitigate target motion (e.g., compression, breath hold,
ventilation) (26, 27). Although, applications of combinations of
these can be effective, the selected treatment approach generally
depends on individual patient and tumor conditions (28), as well
as on site-specific irradiation capabilities (17).
Of the different patient-assisted motion mitigation techniques
available, suppression of ventilation via active or passive breath
holding seems to be among the most promising (17). Important
in this context is the duration of motion suppression and its
influence on the stability of lung structure and volumes. For
example, considering relationships between tumor volumes and
field application durations for different rescanning scenarios
based on the beam delivery characteristics of, e.g., Gantry-2 at our
institution, realistic rescanning factors are 0–4 with a duration
of 45–90 s for a single field irradiation for tumor volumes up to
1 L. Therefore, with the goal of one breath hold per irradiation
field, breath-hold durations of more than 60–90 s are desirable.
This is longer than the length of unassisted, voluntary breath
holds that typically range between 30 and 70 s and are typically
associated with chest wall movements when subjects approach
the point of termination. Without training, a longer breath-
hold duration can only be achieved either by physiological
interventions prior to an active deep-inspiration breath hold
(DIBH) or via passive “breath holding” using, for example, high-
frequencymechanical ventilation, e.g., high-frequency percussive
ventilation (HFPV) (27).
For active breath holding, however, the challenges are
manifold. First, lung volume and chest wall positions need
to be reproducible in relation to the planning CT (the basis
for treatment). Since the largest breath-hold duration can be
achieved with the largest lung volume, subjects must hold their
breath at maximal inspiration, i.e., at total lung capacity (29,
30). However, measures of lung volumes are known to vary in
response to a person’s experience with performing this specific
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inspiratory maneuver. This implies that on each measurement
day, several full inspirations need to be performed until stable
total lung capacity values are reached (31, 32). Second, breath
holds may be more difficult in supine position, as active breath
hold in daily life is used for stabilizing the trunk during lifting
heavy objects or balancing, in contrast to the relaxed supine
position. Furthermore, additional weight with abdominal obesity
may cause further objective or subjective problems. Third,
coughing is one of the most common symptoms of lung cancer.
The majority of lung cancer patients are current or former
smokers, potentially also suffering from chronic obstructive
pulmonary disease (COPD) which is also accompanied by
frequent coughing due to bronchitis. Tussive irritation may, in
turn, lead to early termination of breath holding, a problemmost
likely to be mitigated through medication.
Perhaps the most limiting factor of breath-hold duration,
however, is the so-called break-point, where perception of
intolerable air hunger urges subjects to take a new breath. This
depends on the interplay of multiple factors. First, rises in arterial
CO2-partial pressure (PaCO2) stimulate the respiratory motor
output via chemoreceptors, giving rise to air hunger. Second,
the ability of the subject to suppress respiratory motor output
and/or tolerate the lack of rhythmical input from lung and chest
wall stretch receptors (33, 34) also limit breath-hold duration.
Third, also decreases in O2-partial pressure (PaO2) that stimulate
respiratory motor output via chemoreceptors also rise to air
hunger—an effect important mainly during breath holding after
prior hyperventilation. Importantly, the O2 available depends
on lung size that decreases with age, is lower in women, and is
often reduced by tumor tissue itself. Also, during extended breath
holds, lung volume can decrease, since less CO2 is produced than
the O2 that is consumed. Last, the psychological state of a person
also contributes to the level of perceived air hunger (35). Thus, an
anxious person may reach the break-point earlier.
On the other hand, it has also been demonstrated that breath-
hold duration can be extended using a variety of techniques. For
instance, hyperventilation prior to breath holding decreases the
starting PaCO2 and thus leads to delayed chemoreceptor and
ventilatory stimulation. As a small risk for passing out exists
with hyperventilation, however, the level of PaCO2 needs to
be controlled for patient safety. Training of the subjects, by
which they become familiar to the suppression of the automatic
respiratory motor output and to the lack of stretch receptor
input, has also been shown to extend breath-hold duration (36).
Finally, extended breath-hold duration has been demonstrated
by breathing a gas mixture with increased PaO2 leading to
delayed chemoreceptor and thus ventilatory stimulation when
PaO2 decreases (37, 38).
Similarly, passive breath holding via HFPV is not without
challenges for conscious subjects. First, patients need to “hold”
a mouthpiece tightly in their mouth while fully relaxing muscles
of the chest and the diaphragm. It is yet unknown whether
this technique can be trained by repeated application. Normally,
a patient in need of HFPV is sedated or unconscious in the
intensive care unit. Second, the pressure applied, and the level
of muscle relaxation, greatly affects pulmonary compliance and
therefore lung volume at a given pressure, thus, potentially
affecting the location of anatomical structures. Finally, HFPV
may induce motion artifacts due to the vibrating nature of this
type of ventilation. Although, expected to be in the millimeter
range, this could be of considerable importance for its application
in proton therapy. Despite these limitations, as both active and
passive breath-hold techniques can substantially reduce motion
amplitudes, they could be of considerable interest in radio- and
proton therapy as effective motion mitigation techniques.
The aim of the present study therefore, was to compare,
in healthy volunteers, intrasession, and intersession variability
of lung volumes, position of anatomical lung structures, and
breath-hold durations between physiologically modified oxygen-
enhancedDIBH (eDIBH) andHFPV over the duration of 3 weeks
in order to simulate fractionated radiotherapy treatment regimes.
Longitudinal breath-hold duration, lung volume measurement,
and magnetic resonance imaging (MRI) were used to assess
variability in volunteers performing daily breath-hold training.
MATERIALS AND METHODS
Participants
Twenty-one healthy subjects (12 males, 9 females) participated
in the study (Table 1). Inclusion criteria were absence of
physical and mental impairment or disease, age ≥40 years, and
ability to give informed consent by signature. Subjects were
excluded, if they had contraindications to MRI procedures,
i.e., non-MRI-suitable electronic and metal implants or
claustrophobia, impaired lung function, acute or chronic disease,
known or suspected non-compliance, drug or alcohol abuse,
inability to follow the procedures of the study (e.g., due to
language problems, psychological disorders, or dementia of
the participant), presence of any psychological or sociological
condition potentially hampering compliance with the study
protocol or, for women, pregnancy, or breastfeeding. Subjects
were informed about all procedures, and all devices were shown
and explained before subjects signed an informed consent prior
to the first data collection. The study was approved by the
Cantonal Ethics Committee NorthWest and Central Switzerland
(BASEC-ID: 2018-01295; Clinical trial number NCT03669341).
Study Protocol
Subjects visited the Center for Proton Therapy at the Paul
Scherrer Institute (PSI, Villigen, Switzerland) for MRI
acquisitions on four different occasions. Visits were interspersed
by 6 days of home-based breath-hold training. A schematic of
the study protocol is displayed in Figure 1. In addition, a fifth
visit was arranged for four selected subjects who demonstrated
long breath-hold durations whereby three MRI acquisitions were
performed within the same breath hold.
At the first visit, subjects were thoroughly informed about all
details of the study procedures, including a demonstration of
all testing equipment. After signing the informed consent form,
a questionnaire-based assessment regarding cardiovascular risk
factors and exclusion criteria was performed. Then, subjects were
briefly asked about activity, nutrition, and sleep over the past
24 h, which they were requested to keep as similar as possible
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before each of the following visits to assure a similar metabolic
and psychological status.
At all visits, after checking the current health status as well
as activity, nutrition, and sleep over the past 24 h, lung function
was assessed by performing forced spirometry. This served to
exclude a potentially undiagnosed lung disease affecting lung
volume and/or respiratory mechanics and to achieve maximal
lung volumes for breath holding because forced spirometry,
TABLE 1 | Demographic data of subject cohort.
Parameter Males Females p
(n = 12) (n = 9)
Age [years] 50.7 ± 6.4 47.9 ± 4.6 0.496
Height [cm] 183.2 ± 5.3 167.8 ± 5.0 <0.001
Weight [kg] 89.0 ± 9.5 62.9 ± 9.5 <0.001
BMI [kg·m−2 ] 26.5 ± 2.4 22.3 ± 2.7 0.003
Data presented as mean ± SD. BMI: Body mass index.
yielding FVC, requires repeatedmaximal inspiration until similar
volumes are reached (31).
Thereafter, and as with home training, two DIBH of maximal
duration were performed in sitting position, the first out of
resting breathing, the second after three deep breaths (to decrease
PaCO2 slightly and prolong breath-hold duration).
Next, the subjects were transferred to the MR scanner
and positioned on the couch in supine position according
to a positioning under treatment. Measurement devices for
the assessment of heart rate (HR) and peripheral blood
oxygen saturation (SpO2) were used to assure subject’s safety
throughout the procedure. Also, respiratory CO2 concentration
was measured to control the level of hyperventilation. Subjects
also were fitted with a face mask for delivery of 100% O2 during
hyperventilation prior to breath-holding in the MR scanner.
One enhanced DIBH (eDIBH) procedure was then performed
to determine the maximum breath-hold duration. Thereafter,
subjects were moved by the MR couch into the scanner ring
head first and a laser alignment (for reproducible interfractional
positioning between weekly visits including wing board settings)
followed. During two immediately consecutive MRI acquisitions
FIGURE 1 | Study protocol. Visits at the Paul Scherrer Institute (PSI) were interspersed by 6 days of home-based breath-hold training with four deep-inspiration
breath holds (DIBHs) of maximal duration, two in sitting and two in supine position. The first three breath holds were performed out of resting breathing, the fourth after
three deep breaths. At visits, first spirometry was performed, followed by two DIBHs of maximal duration in sitting position, the second one performed after three deep
breaths. The third breath hold prior to magnetic resonance image (MRI) acquisitions was performed after ≥8min of breathing 100% O2 with hyperventilation (at an
end-tidal CO2-partial pressure of 20 mmHg) for the last 5min prior to this maximal enhanced DIBH (eDIBH). This procedure was immediately followed by moving the
subject into the MR scanner, initiating the eDIBH-procedure prior to each of two consecutive MRI acquisitions and maintaining it during image acquisitions. After
moving the subject out of the MR scanner and installing the high-frequency percussion ventilator (HFPV), the subject was moved into the scanner ring again for two
consecutive MRIs under HFPV conditions.
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performed to simulate intrafractional treatment conditions with
multiple fields, subjects were asked to perform two separate
eDIBHs, one for each scan. Afterwards, subjects were moved out
of the MR scanner to return to resting breathing and allowed to
move (still on the couch).
Subsequently, details of the HFPV procedure were explained
again and subjects were connected to the HFPV device. A
first HFPV trial was performed outside the MR scanner for
familiarization purposes, to adjust the HFPV settings accordingly
and to test whether the tolerated HFPV duration was sufficient
for a single MRI acquisition. Subjects were then repositioned and
moved back into the MR scanner, where two consecutive MRI
acquisitions were performed, in analogy to the two eDIBHs.
At the end of the first session, subjects additionally received
instructions on performance and recording of their daily, home-
based breath-hold training which was recorded in a personal
logbook (see Section Training and Measurements at Home
for details).
Measurements and Interventions During
Each Visit
Lung Function Measurement
Forced spirometry was performed to assess FVC as well as
maximal inspiratory and expiratory flow rates via a hand-held
spirometer (Spirobank, MIR, Rome, Italy). Measurements were
performed according to criteria of the American Thoracic Society
and the European Respiratory Society (31). An adequate test
required a minimum of three acceptable maneuvers and meeting
the reproducibility criteria according to the ATS/ERS statement.
If these criteria were not met, additional trials were performed
until criteria were met but no more than eight maneuvers
were performed.
Motion Suppression Techniques
The eDIBH procedure was performed as follows: In resting,
supine position, subjects breathed 100% O2 via face mask for
at least 8min with (i) 3min resting breathing followed by
(ii) controlled hyperventilation where subjects were coached to
perform deep inspirations and expirations such that a PETCO2 of
20 mmHg (2.67 kPa) was maintained for 5min, followed by (iii)
a maximal deep inspiration, which was sustained for as long as
possible. A second and third eDIBH was performed during the
following MR scans, where eDIBH was maintained during image
acquisition for 70 s.
HFPV is based on the administration of small volumes of air,
so-called percussions, with adjustable pressures and frequencies.
These percussions can replace spontaneous ventilation allowing
prolonged apnea-like suppression of respiratory motion while
maintaining adequate oxygen diffusion and CO2 removal.
The HFPV procedure was performed using a jet ventilator
(Monsoon R© Jet Ventilation, ACUTRONIC Medical Systems,
Hirzel, Switzerland), positioned in the MR control room (outside
the magnetic scanner region). The ventilator was connected
by an 8-m pressure tube to an open circuit breathing-adapter
(Phasitron R©, Percussionaire Suisse, Ardon, Switzerland) that
subjects held in their mouth via mouthpiece with a nose clip
in place. The familiarization trial outside the MR scanner was
performed using 1.0-bar pressure pulses at a frequency of 250
pulses min−1. Individual adjustments of pressure and frequency
were made according to subjective comfort and the subjects’
ability to relax while being passively ventilated. During the MRI
acquisitions, individualized pressure pulses ranged from 0.8 to
1.2 bar with a frequencies of 225–250 pulses min−1.
MR Positioning and Image Acquisition
Subjects were immobilized on the MR couch using (i) a
removable wing board attached to it with a central head support
and adjustable fixation rods, which were held by both hands
with arms supported overhead, and (ii) a knee support without
additional fixation devices.
For all image acquisitions in the MR scanner (MAGNETOM
Aera, 1.5 T, Siemens Healthcare AG, Zurich, Switzerland) a T2-
weighted, 2D-steady-state free precision (SSFP) sequence was
used. Voxel spacing was 0.7617 by 0.7617 mm2 in plane with
a plane separation of 2.2mm; the reconstructed image plane
consisted of an array of 512 × 512 pixels. Approximately 100
coronal 2D image planes were acquired in about 70 s.
Visit 5 for Selected Subjects
Four subjects that were capable of maintaining eDIBH for at least
4min were recruited for an additional session to assess changes
in lung volume during prolonged breath-holding. During this
fifth visit, only the eDIBH procedure was performed. The visit
consisted of two separate MRI acquisitions, each with three
consecutive MR sequences, and each performed over a period of
210 s during a single eDIBH.
Subjective Assessment of Interventions
At the end of visit 4, acceptance of breath-hold training at
home and levels of “comfort/tolerability” of eDIBH or HFPV
procedures during theMRI acquisition were assessed using visual
analog scales with the anchors “feasible”/“not feasible” and “well-
tolerable”/“not tolerable.” Finally, the subjects were asked which
of the two techniques for respiratory motion mitigation they
would prefer as a patient.
Training and Measurements at Home
Home-based breath-hold training consisted of four maximal
DIBHs per day for a total of 18 days in order to get used to these
respiratory maneuvers including full inspirations. The first and
second DIBH was performed in sitting position, out of resting
breathing as this is more comfortable and to allow comparison
with the same breath-hold technique in lying position. The
third and fourth DIBH were performed in lying position, with
the first of these two also starting from resting breathing (to
be compared with sitting) while the second was initiated after
three deep inspirations and expirations to show the subject that
“hyperventilation” increases breath-hold duration and to get
them used to long-duration breath holds. Breath-hold durations
were recorded by the subject in a logbook and correct recording
was double-checked at each lab visit.
Data Analysis and Statistics
Anthropometric data were compared between sexes using the
Mann-Whitney U test.
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Breath-Hold Duration, Forced Vital Capacity, and
Subjective Assessment
In order to evaluate the effects of sex and repeated visits, breath-
hold durations as well as forced vital capacities were analyzed
using two-way analysis of variance (ANOVA) with repeated
measures and Bonferroni corrections for post-hoc analyses. If
data were not normally distributed, a related-sample Friedman
test was performed and the Wilcoxon signed rank test used
for post-hoc analysis. Effects of breath-hold methods and sex
in time-averaged home training (18 days average), visit (four
visits average), and subjective data were analyzed using paired t-
tests or Wilcoxon matched-pairs signed rank test. For correlation
analysis between breath hold and spirometry variables, Pearson’s
correlation coefficient was calculated if data were normally
distributed and Spearman’s correlation coefficient if data were
not normally distributed. One subject was excluded from all
breath-hold analyses due to incomplete data. GraphPad Prism
2019 (GraphPad Software, La Jolla California, USA) was used for
statistical analysis and data presentation.
Lung Volume Analysis
Based on the repeated MRI acquisitions using both eDIBH
and HFPV inter- and intrafractional lung volumes and
displacements have been determined and compared. Total lung
volumes were determined from each acquired MRI using an
automatic segmentation program developed in-house. Using
functions provided by the Image Processing Toolbox of MatLab
(R2018b, The MathWorks, Inc., Natick, Massachusetts, USA),
the program imported and saved image data in DICOM
format. The algorithm first processed the image volume
as suggested in the step “Mark the Foreground Objects”
in the MatLab documentation section: “Marker-Controlled
Watershed Segmentation.” A voxel threshold was selected by an
adaptive algorithm for each image plane and the segmentation
effected using the functions bwlabel.m and regionprops.m. The
final step in the algorithm was the application of the 3D-
clustering program, spm_cluster.m of the statistical parametric
mapping package SPM12 (https://www.fil.ion.ucl.ac.uk/spm/
software/spm12/). Two-way unbalanced ANOVAs evaluated
the effects of visit, motion-mitigation method, and sex. For
the four subjects studied for lung volume decreases during
the acquisitions (fifth visit), the volumes were normalized
by the initial volumes to yield a fractional decrease during
the acquisition.
Measuring Intra- and Interfractional Lung
Displacements
To simulate potential intra- and interfractional variations in lung
volume and form as part of a radiotherapy treatment, in this
study, it has been assumed that the breath-hold duration of a
patient with eDIBH is sufficient for the complete irradiation
of one field. That is, each single MRI reflects lung position
and shape for an individual irradiation field, with each fourfold
weekly repetition of two consecutive MRI sequences then
representing four irradiation fractions, each consisting of two
fields. As such, variations between MRIs in the same session
represent inter-field variations, whereas, variations between
sessions represent potential interfraction variations. In addition,
variations of intrafield conditions, i.e., intrabreath-hold changes
in lung volume, were evaluated by the acquisition of the three
consecutive MRIs within one eDIBH in selected subjects.
In order to investigate the spatial variation of key anatomical
lung structures (LSCs) over therapy sessions, a reference point
was selected (RefSC = LSC4) which does not move during
respiration in the supine position. The chosen reference point
was a prominent paravertebral part of one of the posterior
intercostal veins on the level of the middle thoracic vertebral
column (T4–T8). As shown in Figure 2, the selected anatomical
structures subject to movement were (i) the ribs in the apex
areas of the lung (LSC1), (ii) the carina tracheae (LSC2),
(iii) the diaphragm (LSC3), and (iv) the branching points of
six specific lung vessels representing hypothetic intrapulmonal
tumor locations (LSC5-LSC10). The distribution of the six vessels
observed an even division in the craniocaudal direction. With
an extension from the apex to the costodiaphragmatic cavity,
projections on the junctions of the T5/T6 vertebras and T9/T10
were selected, which defined three segments of approximately
equal length. On each side of a segment were then located two
vessels. Using Velocity R©, trained medical assistants located the
reference point and anatomical structures manually; two of the
authors (FE andMW) checked the locations. The set of difference
vectors ri between the locations, RefSC and LSCi, is denoted as an
intrapulmonary lung structure metric. Using these metrics, two
analyses have been performed.
First, the radial distance ri = |ri| of the distance vector ri,
was determined for each MRI acquisition. From the sets of eight
MRIs (two scans at four visits) acquired for each subject, the
mean radial distances of each lung structure µ(ri, M) and their
standard deviations σ (ri, M) were determined for each method
M: eDIBH or HFPV. The ratios σ (ri, eDIBH)/µ(ri, eDIBH)
and σ (ri, HFPV)/µ(ri, HFPV) yielded fractional variations, for
which medians, maxima, and distributions of ranks according to
the Wilcoxon signed rank test could be compared. In addition,








of the two methods provided a comparison of methods for each
subject and lung structure.
Second, as shown schematically in Figure 3, we evaluated
(i) the distributions in each subject after corrections for
interfractional shifts due to repositioning and (ii) intrafractional
differences due to different lung volumes during the consecutive
eDIBH or HFPV MRI acquisitions. The analysis consisted of
three steps.
(A) After contouring, the spatial distributions of all 10 LSCs
were determined in the DICOM reference system of
all 16 MRIs: 8 × eDIBH and 8 × HFPV, without
positioning correction.
(B) Interfractional shifts were described as rigid-body
transformations. These were treated in Velocity R© as
pairwise image registrations with respect to the reference
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FIGURE 2 | Representation of lung structure metric with selected LSCs. LSC distribution as described in the text (image courtesy of Visible Body®).
point RefSC on the spine between the first MRI of visit 1
(MRI1) as reference and the following MRIs from visits
2 to 4 (MRI3 to MRI8). The transformation between
MRI1 and the second MRI of visit 1 (MRI2) was assumed
to be negligible. In the other registrations, the MRIs were
superimposed in such a way that the spinal column structure
was optimally covered. The resulting six transformation
matrices were then exported as DICOM registration objects
and imported into MatLab. In order to simulate the 3D
positioning offset correction applied in Gantry-2 before
each irradiation fraction, only the translation components
of the transformation were included in the analysis. These
interfractional translation corrections were applied to
the corresponding spatial distributions of the LSCs given
in (A). For each subject and method, the resulting LSC
distributions in Cartesian DICOM space yield clusters of
position variabilities.
(C) The standard deviations about the mean positions of each
LSC-specific cluster yielded a 95% CL ellipsoid, the volume
of which, denoted “volume of variability” (VolOfVar),
represented an empirical measure of spatial variability.
Division of the VolOfVar by the mean subject lung volume
delivered a fractional volume of variability. As for the
radial distances, the logarithm of the ratio of fractional
variations between the two methods for each subject
and lung structure yielded a subject-specific comparison
of variability.
RESULTS
Breath-Hold Duration and Subject
Acceptance
Subjective Acceptance
On a scale ranging between 0 and 10, where 0 was the best
rating, the subjects rated home-based training as being “feasible”:
2.2 ± 2.1, as they also rated eDIBH and HFPV methods: 1.4 ±
1.1 and 2.2 ± 2.5, respectively. Both methods were also rated
“tolerable” for patients: 1.8 ± 2.2 and 2.5 ± 2.7, respectively.
Wilcoxon signed rank tests evidenced no difference between the
two methods in neither “feasibility” nor “tolerability.” However,
14 of the 21 subjects preferred eDIBH to HFPV; an experience
of “less discomfort” during eDIBH was named as the most
frequent reason.
Effect of Breath-Hold Training in Sitting Position Over
Time
Breath-hold training at home revealed no change in breath-
hold duration in sitting subjects across 18 training days and 4
visits (Figure 4), while a significant effect of time was detected
in breath-hold durations assessed at visits (p = 0.035), despite
breath-hold durations at visits being similar to those assessed at
home at these specific time-points (p = 0.444). The difference
was located between visit 1 and visit 2 (p = 0.034). Three deep
breaths prior to a maximal DIBH significantly increased breath-
hold duration at home inmales (18-day average without 77± 28 s
Frontiers in Oncology | www.frontiersin.org 7 April 2021 | Volume 11 | Article 621350
Emert et al. eDIBH for Respiratory Motion Mitigation
FIGURE 3 | LSC volumes of variability. Principal steps of displaying, processing, and analyzing a lung structure metric for a subject-specific set of eight MRIs acquired
for eDIBH or HFPV. Top to bottom: LSCs were contoured as RT-STRUCT sets in Velocity® (A) followed by DICOM export/import into MatLab to enable visualization in
the common DICOM Frame of Reference. Subsequently (B) translation corrections determined by rigid-body image registrations were applied to the LSC distributions
identified on left side graph, and (C) rotational ellipsoids to approximate their spatial distributions were calculated as described in the text.
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FIGURE 4 | Sex-specific group mean maximal DIBH durations (± standard deviation) at home and at visits. *p < 0.05; #p = 0.010.
and with three deep breaths 120 ± 46 s; p < 0.001) and females
(from 56 ± 9 s to 84 ± 18 s; p < 0.001). Also during visits, 3
deep breaths increased breath-hold duration in males (average of
four visits without deep breaths: 80 ± 26 s, average of four visits
with three deep breaths: 111 ± 38 s, p < 0.001) and in females
(from 59 ± 7 s to 76 ± 11 s; p < 0.001). A significant time-effect
was detected that was located post-hoc between Visit 1 and Visit
2. A significant sex effect was detected with males having longer
breath-hold durations during home trainings (p = 0.010) as well
as at visits (p= 0.038).
Breath-Hold Duration Before MRI Acquisition (eDIBH)
in Lying Position
Enhanced deep-inspiration breath hold duration assessed prior
to the MRI acquisition, i.e., eDIBH duration, was significantly
lower in visit 1 than in the following visits in the entire group.
However, only in males, these differences were present without
significant differences between visits in females (Figure 5).
Individual breath-hold durations show, that all but one subject
reached the required 90 s eDIBH duration at all four visits. DIBH
durations assessed in sitting position at home were significantly
correlated with eDIBH durations in lying position assessed prior
to MRI acquisitions (Figure 6). The correlation coefficients for
the different visits were similar: visit 1: r2 = 0.520, p < 0.001;
visit 2: r2 = 0.392, p = 0.003; visit 3: r2 = 0.637, p < 0.001;
visit 4: r2 = 0.567, p < 0.001. Similarly, sitting breath-hold
durations at visits were significantly correlated with eDIBH
durations; r2 = 0.672, p < 0.001.
Lung Volume Analysis
Full Inspiration (Forced Vital Capacity)—Changes
Within and Between Days
Across visits, measures of FVC did not differ significantly: visit
1: 5.05 ± 1.25 L; visit 2: 5.06 ± 1.24 L; visit 3: 5.05 ± 1.24 L;
visit 4: 5.07 ± 1.26 L; p = 0.42. However, a sex effect was
detected with males having a larger FVC than females (average
across four visits in males: 5.93 ± 0.89 L; in females: 3.89 ±
0.37 L, p< 0.001). Also, FVC correlated significantly with eDIBH
duration (r2 = 0.306; p < 0.001) although—when sexes were
analyzed separately—a significant correlation was present in
males only (r2 = 0.279; p < 0.001).
To determine FVC according to ATS/ERS criteria (31), an
average number of 5 ± 1 attempts (range 3–8) was necessary
to achieve maximal values on visit 1 while on visit 4 an average
of 3 ± 0 attempts (range 3–4) was needed. On visit 1, all but
two subjects reached maximal values at the fourth attempt at
the latest, while on visit 4, all but one subject reached maximal
values at or prior to the third attempt. Maximal within-subject
differences between selected best values ranged between 0.3
and 3.6%.
Lung Volumes
The segmentation algorithm yielded the lung volumes presented
in Table 2. In addition, their intrafractional variations for each
method at each visit were derived.
As indicated in Table 2, an unbalanced two-way ANOVA
showed no significant variation over visits, p < 0.88, but a
significant difference between methods, p < 0.0001. Further
ANOVAs yielded for neither method a significant variation
over visit, p < 0.99 for eDIBH and p < 0.48 for HFPV, but
significant difference between sexes, p < 0.00001, in both cases.
The average difference between males and females for lung
volume as measured by eDIBH was 2 L, as for FVC.
In neither of the ANOVAs of the intrafractional variations was
there a significant difference over the course of the four visits: p<
0.32 for eDIBH and p < 0.77 for HFPV. The standard deviations
of the intrafractional variations are with the exception of the last
visit twice as large for HFPV as for eDIBH and smaller than
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FIGURE 5 | Individual subject’s maximal-enhanced deep-inspiration breath
hold (eDIBH) duration; black line: group average, dashed line: 90 s duration. *p
< 0.01; ***p < 0.001.
FIGURE 6 | Individual subject’s maximal deep-inspiration breath hold (DIBH)
durations out of resting breathing in sitting position compared with
maximal-enhanced deep-inspiration breath hold (eDIBH) duration in lying
position at all visits. Best-fit line with 95% confidence bands.
the lung volume standard deviations given in the upper part of
Table 2.
Variation of Lung Volume Over Time for eDIBH
Analysis of the variation of intrabreath-hold lung volumes for
the four subjects most capable of long breath-hold durations
(Figure 7) showed that the decrease in lung volume over the
course of the first 70 s acquisition was 5% or less in each of the
four subjects. Themore pronounced decrease in subject 6 (006-1)
was rather due to an image artifact than to a physiological effect.
The measured, maximum 5% decrease in lung volume over a
period corresponding to the radiation time of a single field was
thus below the 10% threshold, which was determined to be a
sufficient determination accuracy for the automated calculation
of lung volumes.
Lung Topography Analysis
Intrafractional Displacement of Lung Structure
Metrics
The first analysis of lung structure metric evaluates the positional
variability of the lung structures via the relative errors of radial
distances ri between RefSC and LSCi, i.e., the quotient of the
standard deviation and the mean value of the LSCi distributions
over all subjects. The analysis yielded no significant correlation
between the relative errors of lung structures and the relative
errors of the computed lung volumes. They can therefore serve
as intrinsic measures of variability.
As given in Table 3, the medians and maxima for almost
all structures are consistently less for eDIBH than for HFPV.
In addition, the Wilcoxon signed rank test yielded significant
differences between methods for the diaphragm, the carina,
and vessels in the lower region of both lungs, VesselLL and
VesselRL, and one in the left mid-lung section, VesselLM. This
indicates a significantly lower positional variability for eDIBH
than for HFPV.
Confirmation of this result on a subject basis was established
by plotting the logarithm of the ratio of relative errors between
eDIBH and HFPV, denoted as γ ratio, for each subject and
LSC. This yielded the three-dimensional bar plot in the upper
part of Figure 8. Augmented by the corresponding ratio of lung
volumes, it summarizes the relative variability of the two motion
mitigation methods. A negative logarithm indicates that the
variability is less for eDIBH, a positive value that the variability
is less for HFPV.
Of the 200 log ratios, 140, i.e., 70%, show less variability
for eDIBH. The subject distribution presented in the resulting
table at the bottom of Figure 8 showed in 11 subjects between
8 and 10 γ ratios favoring eDIBH, whereas, four subjects exhibit
between 0 and 3 of such ratios. Thus, of the 15 subjects showing
a clear distinction, 73% of the subjects show less variability
for eDIBH. The distribution in Figure 8 can be modeled by a
binomial distribution with the two options eDIBH or HFPV,
resulting in a probability of 0.87 for eDIBH. This value indicates
that the above estimates of less variability for eDIBH are
not arbitrary.
Interfractional Displacement of Lung Structure
Metrics
To simulate proton therapy treatment conditions for Gantry-
2@PSI, where setup uncertainties are compensated by linear 3D
offset movements of the couch, the inter-fractional displacements
(contained in the 6 DoF-MRI registration objects) were corrected
by applying their 3D translation components to the respective
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TABLE 2 | All data presented in [l] as mean ± SD.
Visit 1 Visit 2 Visit 3 Visit 4
Lung volumes over course of visits [l]
eDIBH men 6.40 ± 1.44 6.58 ± 1.20 6.58 ± 1.22 6.59 ± 1.12
eDIBH women 4.61 ± 0.54 4.51 ± 0.78 4.39 ± 0.95 4.38 ± 0.90
HFPV men 5.48 ± 1.41 5.24 ± 1.18 5.67 ± 1.51 5.29 ± 1.73
HFPV women 3.20 ± 0.72 3.48 ± 0.94 3.81 ± 0.74 3.74 ± 0.51
Intra-fractional variation of lung volumes [l]
eDIBH 0.160 ± 0.256 0.153 ± 0.364 0.056 ± 0.255 0.020 ± 0.285
HFPV −0.108 ± 0.640 −0.056 ± 0.617 −0.176 ± 0.542 −0.001 ± 0.291
Top: the means and standard deviations of lung volumes over the course of four visits as determined by gender for eDIBH and HFPV; bottom: the means and standard deviations of
the differences between successive measurements of lung volumes for each method at each visit.
FIGURE 7 | Fractional decreases of lung volume with repetition for four
subjects. Each acquisition lasted 70 s. Successive acquisitions were
performed with an interruption of a few seconds for restarting the MR
sequence.
lung structure distributions (see Figure 3). Their remaining
spatial uncertainties are thus composed of (i) the interfractional
rotational components and (ii) the interbreath-hold variations.
Geometrically, rotations around the AP axis result in lateral
displacements. Their amount depends on the distance to the
rotation center RefSC in CC direction. Since the spatial shifts
of lung structures due to respiratory movements are least
pronounced in RL (39), the contribution of uncorrected setup
rotations is greatest in the lateral spatial direction. Assuming
a CC distance of a pulmonary vessel from RefSC of 100mm,
an AP rotation of 3◦ delivers a lateral offset of about 5mm.
A comparison with Figure 9 reveals this value to be a good
approximation to the upper limits for the σRL distributions
of VesselLU and VesselRU displayed in the top row. Larger RL
displacements were measured only for the apex: ∼6–7mm and
diaphragm: ∼8–10mm, as these lung structures are farthest
from the reference point in the CC direction. There are no
TABLE 3 | Median and maximum relative error [%] of radial distances between
reference (RefSC) and selected anatomical structures (LSCi), including significance
of difference between corresponding distributions of eDIBH and HFPV according
to Wilcoxon signed rank test.
Relative errors of radial distances to reference/significance of difference
LSC eDIBH HFPV p
Median Maximum Median Maximum
[%] [%] [%] [%]
Apex 0.7980 1.3164 0.7876 3.2929 0.167
Carina 2.4417 3.8687 3.3148 7.1217 0.014
Diaphragm 2.6896 9.3390 7.7671 25.0294 0.001
VesselLU 1.1106 2.0416 1.2444 3.8462 0.218
VesselLM 1.5520 3.0509 2.3186 3.5505 0.025
VesselLL 1.7521 7.5847 3.7943 13.1986 0.010
VesselRU 1.4460 1.9090 1.4487 4.3269 0.314
VesselRM 2.2613 7.0645 2.3931 6.3809 0.247
VesselRL 3.6881 16.3864 7.7566 21.1520 0.014
significant differences between eDIBH and HFPV regarding
RL displacements.
In accordance with the intrafractional displacements
discussed in Section Intra-Fractional Displacement of Lung
Structure Metrics, the most significant differences between
eDIBH and HFPV in spatial variability are found in the CC and
AP directions for the diaphragm, carina and for the vessels of the
lower and middle left lung segment.
Analogous to the relationship between rotational distribution
and RL shifts, the contributions of pitch and roll components
to the linear shifts of lung structures in the CC and AP
direction can be estimated geometrically. Calculations reveal that
only about 10–20% of these displacements are caused by the
uncorrected rotations about the RL and CC axes, respectively; the
variation in lung volumes due to eDIBH or HFPV represent the
dominant factor.
This presentation of lung structure variability in Cartesian
space concludes with analysis of comparison of the relative
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FIGURE 8 | The 3D bar plot displays the logarithm of the ratio, denoted γ, of relative errors in lung structure radial distances and volumes between the motion
mitigation methods, eDIBH and HFPV, for each subject, and lung structure or volume. The lower table assigns to each subject the number of values for which the γ
ratio is negative, indicating less variability with eDIBH. Green indicates numbers >7, orange those <4. White indicates intermediate numbers.
volumes of variability: VolOfVareDIBH and VolOfVarHFPV,
determined by the ratio between the 95% CL ellipsoid volume
and the mean subject lung volume for each subject and lung
vessel structure.
The logarithm of the ratio of eDIBH and HFPV relative
volumes is shown in Figure 10 as 2D bar plots. Of the 120
ratios which could be determined, 85 showed less variability
with eDIBH, i.e., 71%, confirming the analysis of relative errors
in radial distances presented earlier. However, only 10 of the
20 subjects showed exclusively less variability with eDIBH,
whereas, three showed exclusively less variability with HFPV; the
remaining seven subjects exhibited mixed variabilities.
DISCUSSION
External beam radiation therapy is a highly effective modality
in the treatment of lung tumors, yielding similar outcomes
as surgery, particularly for early stage non-small-cell lung
carcinoma [NSCLC; (40, 41)]. Appropriate respiratory
motion management approaches (17), however, are of great
importance, especially for PBS-PT (42). As such, breath
holding is an effective method to minimize respiratory motion,
which is well-established in conventional RT treatments
of breast cancer and mediastinal lymphoma (43–46). Its
combination with hyperventilation and/or preoxygenation
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FIGURE 9 | Standard deviations about the mean positions of each LSC-specific cluster in Cartesian coordinates for eDIBH and HFPV (see Section Measuring Intra-
and Interfractional Lung Displacements and Figure 3). The coordinates are labeled in table notation: RL (top row), AP (middle row), and CC (lower row).
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FIGURE 10 | For each subject and lung vessel are plotted the logarithm of the
ratio of relative volumes of variability determined from the 95% CL ellipsoids of
variability between the eDIBH and HFPV. Negative values indicate lesser
variability with eDIBH, positive values lesser variability with HFPV.
for breast irradiation with photons has already been
reported (47).
Several studies investigated the use of DIBH for lung
cancer RT (26, 39, 48–50). However, clinical breath-hold
implementations in proton therapy of lung tumors are currently
predominated by device-assisted breath-hold techniques
(17, 51–53). Training or coaching, however, is deemed necessary
for patient applications, with autonomous breath holding with
or without monitoring being the exception. To the authors’
knowledge, however, no reports of practical implementation for
patient-controlled DIBH supported by physiological measures
(hyperventilation, preoxygenation, breath-hold training)
are available for application in proton therapy, and only
few studies have related breath-hold duration to treatment
delivery time. Indeed, the Particle Therapy Cooperative Group
(PTCOG) guidelines (54) for implementing PBS-PT in thoracic
malignancies consider DIBH to be a realistic clinical treatment
approach. However, they also caution that small highly mobile
tumors potentially causing large baseline drifts are a significant
risk for a consistent DIBH application. Research and clinical
practice in the field of motion management for particle
therapy, however, has primarily focused on adapting to motion
(rescanning, gating, etc.,) rather than effectively mitigating it
by eliminating or reducing patient organ motion, e.g., through
breath hold.
Following the assumption that effective motion management
starts with mitigation, the change in breath-hold duration
with breath-hold training and the use of hyperventilation
combined with oxygenation were investigated in the present
study with 21 healthy subjects. UsingMRI assessment to simulate
realistic PT treatment conditions, the newly proposed eDIBH
and the established HFPV application for respiratory motion
suppression were investigated with respect to lung volume
variability and reproducibility of lung topographies. The aim
of these measurements was the evaluation of applicability
and effectiveness of both methods. Since the use of eDIBH
envisages breath-hold training prior to the start of proton
therapy, not only the effect on breath-hold duration over
the study period was analyzed, but also subjects’ acceptance
of the eDIBH approach compared to the HFPV method
was determined.
The main results of the present study demonstrated that by
the use of breath-hold training and DIBH enhanced by prior
hyperventilation in hyperoxic conditions, breath-hold durations
could be increased from 173 ± 73 s on visit 1 to 217 ± 67 s on
visit 4, with maximal eDIBH durations in all but one individual
subject reaching an eDIBH duration of ≥90 s already at visit
1. The achieved breath-hold durations were similar or longer
than the time required to deliver representative PBS proton
treatment fields at PSI’s Gantry-2 for typical lung tumors. A
recent study using a different method to extend breath-hold
duration in pulmonary patients (a majority with stage III lung
cancer) reported a mean breath-hold duration of 78 s (range
29–223 s) during conventional RT treatment (55). Thus, the
increase in breath-hold duration by eDIBH in the healthy
subjects of the present study is likely transferrable to lung
cancer patients allowing irradiation of adequate PBS-PT fields.
Importantly also, lung volumes determined prior to and during
breath holds, did not change over the course of four visits. In
addition, an important advantage of eDIBH found in this work
results from the fact that subjective tolerance of eDIBH was
similar to HFPV and presumed, by study subjects, tolerable for
patients. Also, home training was given a good rating. Indeed,
of the 18 subjects expressing a distinct preference, 14 (∼80%)
preferred eDIBH to HFPV. Also, during the study, no adverse
events occurred with eDIBH, but one subject was unable to
tolerate HFPV.
Detailed analysis showed that lung volumes determined with
spirometry and during eDIBH in the MR were larger in males
than females. This translated into a tendency for shorter eDIBH
duration in females compared to males. Nevertheless, in this
female cohort, breath-hold duration was still long enough for
a PRT with 141 ± 36 s already on visit 1. The fact that
breath-hold duration in both sexes did not change significantly
after visit 2 suggests that 1 week of individual home-based
breath-hold training with four daily maximal DIBHs, including
reassurance of the possibility to extend breath-holds, e.g., by
prior deep breathing (56), is sufficient to achieve maximal
breath-hold durations. Also, the good correlation found in this
study between maximal sitting DIBHs at home and maximal
eDIBHs could possibly allow to predict in future patients,
already after 1 week of home-based DIBH-training, whether
individual patients’ breath holds will be of sufficient duration for
effective irradiation.
While sufficiently long breath hold durations are essential, it is
equally crucial to achieve consistently similar lung volumes and
lung topographies over all irradiation days. As for reproducibility
of lung volume, no significant difference in FVC and in inter-
fractional variability was observed over the course of four visits,
with intrafractional deviations being <10% of the standard
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deviation of uncertainty of the volume measurements. Thus,
lung volume was reproducible and stable over the study course,
especially also within each visit. During extended breath holds
over the duration of three consecutive, identical MRI sequences,
however, as tested on a sub-set of subjects, lung volumewas found
to decrease significantly after the second sequence repetition.
This effects results from the ongoing metabolism where burning
a mixture of carbohydrate and fat produces a smaller volume
of CO2 than the volume of O2 consumed in a given time
period (respiratory quotient <1.0). Nevertheless, such volume
reductions stayed below 5% over the first and second MRI
sequence, which is less than the uncertainty in intrafractional
volume determination.
The advantages of eDIBH became evident in the analysis of
lung structure positional variability based on a lung structure
metric. Five of nine absolute distances between mobile lung
structures and a static reference structure at the spine showed,
averaged over all subjects, significantly less variability of relative
error for eDIBH than for HFPV. These were the carina,
diaphragm, and the vessels in the left and right lower lung
segment and in the left-middle lung region. The introduction
of a subject- and lung structure-specific measure to determine
distance variability between eDIBH and HFPV defined by the
logarithmic ratio of their relative errors indicated that eDIBH
exhibited at least a 70% advantage compared to HFPV. This
result was derived from the total number of ratios calculated, as
well as by the overall number of subjects showing less variability
for eDIBH.
In addition, an approximation of the intrafractional, spatial
distribution of the 10 lung structures across all MRIs of
each subject provided —after correction of the interfractional
translations and separately for eDIBH and HFPV—their
individual so-called Volume of Variability. In analogy to the
variability of distances, the logarithmic ratio of VolOfVareDIBH,
and VolOfVarHFPV confirmed that the spatial variability for all
investigated pulmonary vessels is smaller under eDIBH than
for HFPV in 71% of cases. The distributions of positional
standard deviations of the 10 lung structures in all three Cartesian
dimensions showed that standard deviations are least for the
reference structures on which the registrations were based, and
most for the diaphragm and for vessels in the lower left and
right lung segment. Their magnitude is higher by a factor of
3 for the diaphragm using HFPV than for eDIBH and by a
factor of 2 for VesselLL and VesselRL with differences between
the methods being most apparent in the anterior-posterior and
cranial-caudal directions.
In summary, the present results can be interpreted in
three ways. Physically, the eDIBH approach has significant
and clear advantages over the HFPV method with respect to
local reproducibility and stability of lung conditions over time.
In practical application, both approaches are feasible under
irradiation conditions with proton therapy, whereby both the
subjective preference of the study participants and the lower
resource requirements speak in favor of eDIBH. Physiologically,
the results suggest that the eDIBH procedure could benefit
patients that need to achieve a breath-hold duration of ≥60–
90 s for irradiation therapy. Although, it can be expected that
such durations can be achieved in cancer patients without lung
morbidity and despite such breath-hold durations having been
reported in lung cancer patients (55), further investigations are
needed to test the extent to which compromised lung function
influences overall breath-hold performance.
In articles related to radiotherapy, average breath-hold
durations of around 22 s are reported for breath holds starting
from resting breathing (47). This is 2- to 3-fold less than breath
holds reported in the present study but in those studies, no or
much less emphasis was put on achieving maximal lung volumes
at the start of those breath holds. Thus, although the present
results are very promising, more research is needed in lung tumor
patients in order to ascertain the benefit of the present eDIBH
procedure in this patient population.
CONCLUSIONS
Both, eDIBH, and HFPV were well-tolerated and eDIBH
duration was long enough to allow potential PRT. Variability
in lung volume and anatomical position of lung structures is
smaller with eDIBH. Also, if given the opportunity to choose,
subjects prefer eDIBH. Thus, eDIBH is a very promising tool
for lung tumor therapy with PRT, and further investigation of its
applicability in patients is warranted.
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